• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于流程映射的皮下植入式心律转复除颤器感染的诊断和管理。

Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping.

机构信息

Division of Infectious Diseases, Department of Medicine, and Department of Cardiovascular Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.

The Ohio State University Wexner Medical Center, Cardiology, DHLRI, Columbus, Ohio.

出版信息

Pacing Clin Electrophysiol. 2020 Sep;43(9):958-965. doi: 10.1111/pace.13902. Epub 2020 Apr 23.

DOI:10.1111/pace.13902
PMID:32267974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7607386/
Abstract

BACKGROUND

Infection is a well-recognized complication of cardiovascular implantable electronic device (CIED) implantation, including the more recently available subcutaneous implantable cardioverter-defibrillator (S-ICD). Although the AHA/ACC/HRS guidelines include recommendations for S-ICD use, currently there are no clinical trial data that address the diagnosis and management of S-ICD infections. Therefore, an expert panel was convened to develop consensus on these topics.

METHODS

A process mapping methodology was used to achieve a primary goal - the development of consensus on the diagnosis and management of S-ICD infections. Two face-to-face meetings of panel experts were conducted to recommend useful information to clinicians in individual patient management of S-ICD infections.

RESULTS

Panel consensus of a stepwise approach in the diagnosis and management was developed to provide guidance in individual patient management.

CONCLUSION

Achieving expert panel consensus by process mapping methodology in S-ICD infection diagnosis and management was attainable, and the results should be helpful in individual patient management.

摘要

背景

感染是心血管植入式电子设备(CIED)植入的一种公认的并发症,包括最近出现的皮下植入式心律转复除颤器(S-ICD)。尽管 AHA/ACC/HRS 指南包括 S-ICD 使用的建议,但目前尚无临床试验数据可用于解决 S-ICD 感染的诊断和管理问题。因此,召集了一个专家小组来就这些问题达成共识。

方法

使用流程映射方法实现了一个主要目标 - 就 S-ICD 感染的诊断和管理达成共识。进行了两次专家组面对面会议,为个别患者的 S-ICD 感染管理推荐了对临床医生有用的信息。

结果

制定了诊断和管理的逐步方法的小组共识,为个别患者管理提供指导。

结论

通过流程映射方法在 S-ICD 感染诊断和管理方面达成专家小组共识是可行的,结果应有助于个别患者的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0094/7607386/fce0e461edba/PACE-43-958-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0094/7607386/2b53e9b9a8d3/PACE-43-958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0094/7607386/fce0e461edba/PACE-43-958-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0094/7607386/2b53e9b9a8d3/PACE-43-958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0094/7607386/fce0e461edba/PACE-43-958-g002.jpg

相似文献

1
Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping.基于流程映射的皮下植入式心律转复除颤器感染的诊断和管理。
Pacing Clin Electrophysiol. 2020 Sep;43(9):958-965. doi: 10.1111/pace.13902. Epub 2020 Apr 23.
2
Process mapping strategies to prevent subcutaneous implantable cardioverter-defibrillator infections.预防皮下植入式心脏复律除颤器感染的流程映射策略。
J Cardiovasc Electrophysiol. 2022 Jul;33(7):1628-1635. doi: 10.1111/jce.15566. Epub 2022 Jun 9.
3
Pocket infection as a complication of a subcutaneous implantable cardioverter-defibrillator.口袋感染作为皮下植入式心律转复除颤器的一种并发症。
Int J Cardiol. 2014 Dec 15;177(2):616-8. doi: 10.1016/j.ijcard.2014.09.119. Epub 2014 Sep 28.
4
Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physicians.皮下植入式心律转复除颤器植入术的麻醉:来自美国一组医生临床经验的观点。
Pacing Clin Electrophysiol. 2018 Jul;41(7):807-816. doi: 10.1111/pace.13364. Epub 2018 Jun 8.
5
Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.可穿戴除颤器在植入式除颤器取出后对患者的保护益处:来自国家登记处的结果。
JACC Clin Electrophysiol. 2017 Mar;3(3):243-250. doi: 10.1016/j.jacep.2016.09.002. Epub 2016 Nov 23.
6
[Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].[青年心脏性猝死。新型皮下植入式心律转复除颤器S-ICD是一种替代解决方案吗?]
Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):27-31. doi: 10.1016/j.ancard.2014.08.018. Epub 2014 Sep 18.
7
State-of-the-art consensus on non-transvenous implantable cardioverter-defibrillator therapy.非经静脉植入式心律转复除颤器治疗的最新共识。
Clin Cardiol. 2020 Oct;43(10):1084-1092. doi: 10.1002/clc.23432. Epub 2020 Aug 14.
8
The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections.可穿戴式心脏复律除颤器作为植入式心脏转复除颤器(ICD)或心脏再同步化治疗除颤器(CRT-D)相关感染患者再次植入的桥梁。
J Cardiothorac Surg. 2017 Nov 25;12(1):99. doi: 10.1186/s13019-017-0669-2.
9
Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.两切口技术在皮下植入式心律转复除颤器中的应用。
Heart Rhythm. 2013 Aug;10(8):1240-3. doi: 10.1016/j.hrthm.2013.05.016. Epub 2013 May 21.
10
Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.皮下植入式心律转复除颤器在困难临床情况下预防心源性猝死的适应证:法国专家立场文件。
Arch Cardiovasc Dis. 2020 May;113(5):359-366. doi: 10.1016/j.acvd.2020.03.011. Epub 2020 Apr 22.

引用本文的文献

1
Long-Term Complications Related to Cardiac Implantable Electronic Devices.与心脏植入式电子设备相关的长期并发症
J Clin Med. 2025 Mar 18;14(6):2058. doi: 10.3390/jcm14062058.
2
The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective.皮下植入式心脏复律除颤器:患者视角
J Clin Med. 2023 Oct 22;12(20):6675. doi: 10.3390/jcm12206675.
3
Treatment and Prevention of Cardiovascular Implantable Electronic Device (CIED) Infections.心血管植入式电子设备(CIED)感染的治疗与预防

本文引用的文献

1
Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study.三十年来心血管植入式电子设备感染的趋势:一项基于人群的研究。
JACC Clin Electrophysiol. 2019 Sep;5(9):1071-1080. doi: 10.1016/j.jacep.2019.06.016. Epub 2019 Aug 28.
2
Subcutaneous implantable cardioverter-defibrillator in primary and secondary prevention of sudden cardiac death: A meta-analysis.皮下植入式心律转复除颤器在心脏性猝死一级和二级预防中的应用:一项荟萃分析。
Pacing Clin Electrophysiol. 2019 Sep;42(9):1253-1268. doi: 10.1111/pace.13774. Epub 2019 Aug 22.
3
Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
CJC Open. 2022 Aug 10;4(11):946-958. doi: 10.1016/j.cjco.2022.07.010. eCollection 2022 Nov.
4
Effects and Complications of Subcutaneous Implantable Cardioverter-Defibrillator in the Prevention of Sudden Cardiac Death: A Narrative Review.皮下植入式心律转复除颤器预防心源性猝死的效果及并发症:一项叙述性综述
Cureus. 2022 Oct 11;14(10):e30170. doi: 10.7759/cureus.30170. eCollection 2022 Oct.
5
Cardiac Implantable Electronic Devices Infection Assessment, Diagnosis and Management: A Review of the Literature.心脏植入式电子设备感染的评估、诊断与管理:文献综述
J Clin Med. 2022 Oct 6;11(19):5898. doi: 10.3390/jcm11195898.
6
Process mapping strategies to prevent subcutaneous implantable cardioverter-defibrillator infections.预防皮下植入式心脏复律除颤器感染的流程映射策略。
J Cardiovasc Electrophysiol. 2022 Jul;33(7):1628-1635. doi: 10.1111/jce.15566. Epub 2022 Jun 9.
抗菌包膜预防心脏植入式电子设备感染。
N Engl J Med. 2019 May 16;380(20):1895-1905. doi: 10.1056/NEJMoa1901111. Epub 2019 Mar 17.
4
Technique for subcutaneous implantable cardioverter-defibrillator extraction.皮下植入式除颤器取出技术。
J Cardiovasc Electrophysiol. 2019 May;30(5):789-791. doi: 10.1111/jce.13893. Epub 2019 Mar 7.
5
Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.预防心律失常装置感染试验:PADIT 试验。
J Am Coll Cardiol. 2018 Dec 18;72(24):3098-3109. doi: 10.1016/j.jacc.2018.09.068.
6
Merits of FDG PET/CT and Functional Molecular Imaging Over Anatomic Imaging With Echocardiography and CT Angiography for the Diagnosis of Cardiac Device Infections.正电子发射断层扫描/计算机断层扫描(FDG PET/CT)和功能分子成像相对于超声心动图和 CT 血管造影在诊断心脏器械感染中的优势。
JACC Cardiovasc Imaging. 2018 Nov;11(11):1679-1691. doi: 10.1016/j.jcmg.2018.08.026.
7
Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects.随机前瞻性 ATLAS 研究的原理和设计:避免在合适的患者中使用经静脉导线。
Am Heart J. 2019 Jan;207:1-9. doi: 10.1016/j.ahj.2018.09.008. Epub 2018 Oct 9.
8
Infection Management.感染管理
Card Electrophysiol Clin. 2018 Dec;10(4):601-607. doi: 10.1016/j.ccep.2018.04.002.
9
Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation.经静脉植入式心脏复律除颤器(ICD)取出后皮下植入式 ICD 的使用和结局:对当前临床实践的分析及与经静脉 ICD 再植入的比较。
Heart Rhythm. 2019 Apr;16(4):564-571. doi: 10.1016/j.hrthm.2018.10.026. Epub 2018 Oct 24.
10
An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients.经静脉和皮下 ICD 患者的临床结局概述。
Curr Cardiol Rep. 2018 Jul 10;20(9):72. doi: 10.1007/s11886-018-1021-8.